Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02708654 · ClinicalTrials.gov registry record · NA
Automated Hovering for Congestive Heart Failure Patients
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 566
- Enrollment target
NCT02708654: Completed NA study, sponsored by University of Pennsylvania.
NCT02708654 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 566 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02708654, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 566 participants
- Enrollment target
Study Summary
Using a 2-arm, randomized controlled trial (RCT) among CHF patients at the University of Pennsylvania Health System (UPHS), to test the effectiveness of applying automated hovering to improve outcomes among CHF patients at high risk of readmission.
Primary Outcome
Our primary outcome is time to readmission for any cause.The primary comparison will be the times to events compared between the intervention arm and the usual care arm; that is, the primary hypothesis is whether a series of interventions, adapted to the behavior and outcomes of each particular patient, will reduce readmission rates compared to usual care.
Interventions
- BEHAVIORAL Electronic pill bottle
- BEHAVIORAL Bluetooth scale
- BEHAVIORAL Support Partner
- BEHAVIORAL Engagement incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 566 participants |
| Start Date | 2016-05-22 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT02708654 record still lists
NCT02708654 is an interventional study that assigns participants to a tested intervention. The registered 566 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 4 interventions - of which Electronic pill bottle is the first listed.
NCT02708654 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02708654 about?
NCT02708654 is a clinical study titled "Automated Hovering for Congestive Heart Failure Patients". Using a 2-arm, randomized controlled trial (RCT) among CHF patients at the University of Pennsylvania Health System (UPHS), to test the effectiveness of applying automated hovering to improve outcomes among CHF patients at high risk of readmission.
What is the current status of trial NCT02708654?
This trial is currently completed. It is a NA study. The enrollment target is 566 participants. The study started on 2016-05-22. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT02708654?
The interventions under investigation include: Electronic pill bottle (BEHAVIORAL), Bluetooth scale (BEHAVIORAL), Support Partner (BEHAVIORAL), Engagement incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT02708654?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02708654's enrollment target sits among peer trials
566 180th of 2000 higher than 1,821 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05472441 · 568 participants · NA
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI